The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive ...

Key results from the interim analysis of the Phase 3 ENLIGHTED study of Padeliporfin VTP: As of November 5, 2024, the data ...

Sea Ice Today began as a way to make sea ice science and analysis more relevant and accessible. In combination, NASA data and NSIDC expertise provide easy-to-use resources and tools to increase our ...

There have been important recent advances in the management of Crohn's disease, including new classes of biological or small molecule therapies, an appreciation that endoscopic mucosal healing results ...

Modern cricket is increasingly scientific and underpinned by professional analytics. The game's new backroom stars are the ...

PFS in Phase 3 HARMONi study was met with statistical significance, but OS was not. Click here to find out why SMMT stock is ...

Despite mixed results, analysts maintained faith in ivonescimab’s ability to cross over between Eastern and Western patient ...

Regeneron and Sanofi's COPD drug itepekimab cut exacerbations by 27% in one Phase 3 trial, while the second trial did not ...

The Water Supplies Department is conserving water with the use of artificial intelligence-powered technology that helps people to reduce water usage with its goal to save 500,000 cubic metres of water ...

According to data from CoinGecko, the Solana meme market capitalization stands at $11.5 billion as of June 2025, signaling ...

New analysis reveals the ellipsoidal zone's role in predicting geographic atrophy progression, enabling timely interventions ...

GSK & Spero Therapeutics announce PIVOT-PO phase III study for tebipenem HBr stopped early for efficacy following review by IDMC: London, UK Friday, May 30, 2025, 15:00 Hrs [IST] ...